Anti-ARHGAP23 monoclonal antibody

Pre-made anti-ARHGAP23 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ARHGAP23/ARHGAP23 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2348-Ab-1/ GM-Tg-hg-IP2348-Ab-2Anti-Human ARHGAP23 monoclonal antibodyHuman
GM-Tg-rg-IP2348-Ab-1/ GM-Tg-rg-IP2348-Ab-2Anti-Rat ARHGAP23 monoclonal antibodyRat
GM-Tg-mg-IP2348-Ab-1/ GM-Tg-mg-IP2348-Ab-2Anti-Mouse ARHGAP23 monoclonal antibodyMouse
GM-Tg-cynog-IP2348-Ab-1/ GM-Tg-cynog-IP2348-Ab-2Anti-Cynomolgus/ Rhesus macaque ARHGAP23 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2348-Ab-1/ GM-Tg-felg-IP2348-Ab-2Anti-Feline ARHGAP23 monoclonal antibodyFeline
GM-Tg-cang-IP2348-Ab-1/ GM-Tg-cang-IP2348-Ab-2Anti-Canine ARHGAP23 monoclonal antibodyCanine
GM-Tg-bovg-IP2348-Ab-1/ GM-Tg-bovg-IP2348-Ab-2Anti-Bovine ARHGAP23 monoclonal antibodyBovine
GM-Tg-equg-IP2348-Ab-1/ GM-Tg-equg-IP2348-Ab-2Anti-Equine ARHGAP23 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2348-Ab-1/ GM-Tg-hg-IP2348-Ab-2; GM-Tg-rg-IP2348-Ab-1/ GM-Tg-rg-IP2348-Ab-2;
GM-Tg-mg-IP2348-Ab-1/ GM-Tg-mg-IP2348-Ab-2; GM-Tg-cynog-IP2348-Ab-1/ GM-Tg-cynog-IP2348-Ab-2;
GM-Tg-felg-IP2348-Ab-1/ GM-Tg-felg-IP2348-Ab-2; GM-Tg-cang-IP2348-Ab-1/ GM-Tg-cang-IP2348-Ab-2;
GM-Tg-bovg-IP2348-Ab-1/ GM-Tg-bovg-IP2348-Ab-2; GM-Tg-equg-IP2348-Ab-1/ GM-Tg-equg-IP2348-Ab-2
Products NameAnti-ARHGAP23 monoclonal antibody
Formatmab
Target NameARHGAP23
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-ARHGAP23 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2348-Ag-1Recombinant multi-species RHG23/ ARHGAP23 protein


    Target information

    Target IDGM-IP2348
    Target NameARHGAP23
    Gene ID57636,58996,303501,693996,491038,101099089,523030,106782827
    Gene Symbol and SynonymsA330041B18Rik,ARHGAP23
    Uniprot AccessionQ9P227
    Uniprot Entry NameRHG23_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000275832
    Target ClassificationN/A

    The target: ARHGAP23, gene name: ARHGAP23, also named as . The RHO (see ARHA; MIM 165390) family of small GTPases are involved in signal transduction through transmembrane receptors, and they are inactive in the GDP-bound form and active in the GTP-bound form. GTPase-activating proteins, such as ARHGAP23, inactivate RHO family proteins by stimulating their hydrolysis of GTP (Katoh and Katoh, 2004 [PubMed 15254754]).[supplied by OMIM, Mar 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.